Table 2.
Clinical Characteristics
| Baseline (n=152) | Follow‐Up (n=152) | P Valuea | |
|---|---|---|---|
| Anginab | |||
| CCS I | 100 (65.8%) | 107 (70.4%) | 0.39 |
| CCS II | 52 (34.2%) | 45 (29.6%) | 0.39 |
| Biochemical assessment | |||
| TC, mmol/L | 4.56 [3.89–7.13] | 4.28 [3.45–4.98] | 0.023 |
| HDL‐C, mmol/L | 1.29 [1.06–1.54] | 1.29 [1.06–1.62] | 0.88 |
| LDL‐C, mmol/L | 3.52 [2.92–4.67] | 3.89 [3.10–4.12] | 0.45 |
| Triglycerides, mmol/L | 1.46 [0.89–5.00] | 1.06 [0.81–2.55] | 0.21 |
| HbA1c, % | 5.9 [5.10–6.60] | 5.7 [5.10–6.20] | 0.39 |
| CRP, mg/L | 2.57 [0.65–5.52] | 2.14 [1.10–5.11] | 0.92 |
| Contrast media used for CCTA, mL | 50.6±11.3 | 51.2±12.4 | 0.96 |
| Radiation dose of CCTA, mSv | 3.8 [2.7–5.9] | 4.19 [2.81–6.14] | 0.81 |
CCS indicates Canadian Cardiovascular Society; CCTA, coronary computed tomography angiography; CRP, C‐reactive protein; HDL‐C, high‐density lipoprotein cholesterol; LDL‐C, low‐density lipoprotein cholesterol; and TC, total cholesterol.
a
Baseline vs follow‐up.
b
Angina was assessed according to the Canadian Cardiovascular Society Functional Classification of Angina Pectoris.